PharmaTalkRadio

The expert panel of scientific leaders from industry will discuss current formulation and delivery challenges for therapeutic areas (ophthalmology, immunology, oncology infectious disease, and neurodegenerative area disorders). Each panelist will address a specific disease area and discuss the role of drug delivery in the treatment of disease. The panel will also cover currently available delivery...

The expert panel will address the scientific and business challenges and opportunities in this space. Panelists will discuss the difficult nature of providing therapies for diseases of the CNS, covering both device and chemistry-enabled technologies. They will also address questions such as:  Can devices take us where chemistry has not? What advances being made in the field of chemis conjugation t...

Drug Delivery Needs in Oncology Due to the increasing number of parenteral biologic therapies that are administered intravenously, the already high pressure on infusion capacity and healthcare resources is expected further increase. A change from intravenous to subcutaneous dosing has been shown to reduce dosing complexity and overall drug administration related costs. There is keen interest in te...

Track 2: Clinical Operations for IO Trials This section is designed for clinical trial operation executives who want to learn what it takes to execute an IO clinical trial. This is an excellent opportunity to walk through the building blocks of IO clinical trial operations and discuss pitfalls and lessons learned. Plenary Chair: Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck   This...

Building Blocks of IO Trials: This talk will consist of 7 perspectives that identify operational aspects of IO trials, including a patient perspective, site management, 3rd party component, clinical supply chain, a PI perspective, data management and project management. The collaborative talk concludes with a panel discussion and Q&A.   This Discussion was presented at the 2018 Immuno-Oncology...

Endpoints News Industry Report on IO Collaborations and Trends In this episode of Pharma Talk Radio, John Carroll, Editor-in-Chief of Endpoints News, reviewed the build up of the immuno-oncology space over the past few years at the IO360° conference that took place February 2018. Mr Carroll discussed the impact the large amount of money and the extraordinary numbers that have been invested in the...

Mobile Podcast Series #2 CTTI Findings are in from their Mobile Clinical Trials Program: Recommendations on Novel Endpoints CTTI's Mobile in Clinical Trials program was launched three years ago to propose recommendations that clarify the pathway for developing novel endpoints for use in clinical trials from data generated using mobile technology. Jennifer Goldsack shares recommendations and insigh...

Podcast on Mobile in Clinical Trials Series #1 How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes Crescendo Biosciences's CIO, Alex Bangs, reports on how a human-centered design approach was used to create MyRA, an award-winning app for patients living with RA. This podcast comes from the 2017 Mobile in Clinical Trials US event.  The next Mobile in Clinical Trials confe...

The Chief Medical Officer Summit is delighted to present a podcast featuring the Keynote Fireside Chat with Michael Rosenblatt, MD, on Lessons Learned from the Journey of a CMO Leader In this session, Dr Rosenblatt, former Merck CMO, will share his insights on career path decision-making and will compare the experiences and lessons learned from being the CMO on the drug development side versus the...

The Chief Medical Officer Summit is delighted to share a podcast featuring a presentation prepared by Drs Alison Bateman-House and Arthur Caplan of NYU's Division of Medical Ethics on the topic of:   Developing a Pathway for Compassionate Use Cases What should the CMO do when they receive a request? What's the role of the CMO, the FDA and the IRB?Lessons learned from Janssen Case StudyHow do you s...

This podcasts gives you an overview on what to expect for the 2018 Chief Medical Officer Summit in a nutshell. The concept of the CMO Summit came from MPM Capital’s Dr Elizabeth Stoner, who told us that there is a deep need for a Summit that is designed for CMOs and heads of R&D in the emerging biotech space, specifically, where we can cover all the key issues affecting R&D decisions toget...

In this three minute podcast, you get an overview of one of the hottest topics we are covering in a full day 2nd annual event on Clinical Research as a Care Option. (CRAACO). Making clinical trials a care option is arguably the greatest challenge we can collaborate on in bringing patients closer to clinical trials. CRAACO takes place on April 11th at the Boston Marriott Cambridge. We look at how t...

This podcast gives you a five minute overview of the 3rd annual Clinical Trial Collaborations conference, otherwise known as CTC. CTC is a strategic level event focused on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes? CTC is ideal for people working in clinical trial operations, who are involved with ex...

The Mobile in Clinical Trials conference comes to Europe for the first time on May 15th and 16th at the Millennium Gloucester Hotel in London. If you work or want to work with mobile and digital technologies to make clinical trials more efficient and reduce patient burden, we highly recommend this conference for you. Using our past four years of experience in the US, we are able to combine the bes...

Dr Roslyn Schneider, Global Patient Affairs Lead at Pfizer, speaks with Valerie Bowling, Executive Director, Patients as Partners, in a podcast interview on patients at the center of clinical research. Dr Schneider, better known as Roz, helps drive patient centricity and the integration of the patiemt voice throughout the development of medicines at Pfizer. She gives us a brief history of the evol...

DPharm Podcast Series #5 Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D Patient advocate star, Dana Lewis, founder of OpenAPS delivers a powerful session at DPharm on an idea to reduce the burden of type 1 diabetes with a smart system she created through open soucre. Learn how she drive the idea and creation of the "Self driving car for diabetes". The next DPharm co...

 5th Annual Patients as Partners What to Expect Overview Podcast Officially approved by Patients Included, Patients as Partners is the only program in the US that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. Taking place March 15-16 in Philadelphia, the focus of this year’s program is on turnin...

DPharm podcast series # 2  MIT Professor, Dina Katabi, PhD gave one of the best talks on in home non-intrusive patient monitoring at DPharm 2017 and provided a demo of technology that uses ambient radio signals to monitor a patient’s gait, falls, breathing, heart rate and even sleep, all without putting any sensor on the patient’s body. Find out how they have used the technology to redefine clinic...

The Conference Forum presents a 1 day meeting on Immuno-Oncology Clinical Trial Operations, February 8th at the Roosevelt hotel in NYC. It’s part of the IO360 conference, which runs over three days from Feb 7th through the 9th.  The OPERATIONS portion of this conference is offered as a stand alone program.  This podcast gives a brief summary of what to expect. The morning provides first hand repor...

The 2nd annual Patients as Partners EU is the only conference in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. In this short podcast, Valerie Bowling, executive director at the Conference Forum gives a brief summary of what to expect at this conference and runs through the highlights.  Cha...

If you are interested in hearing the 2017 drug delivery landscape year in review in 2017, please email service@tcfllc.org Chair of the Partnership Opportunities in Drug Delivery (PODD) event, Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche, presents an annual year-in-review of the drug delivery landscape from 2016. Dr Lueckel’s opening remarks are a highlight of PODD ever...

Pan American Games Champion, Olympian and World Championship silver medalist, Jennifer Goldsack, became a world-class athlete while working and studying at the University of Oxford. How did she do it? She recently shared her story with DPharm Director, Valerie Bowling, discussing the lessons she learned from her Olympic experience and how she uses them in her professional life at the Clinical Tria...

Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including: Discovery / Preclinical ScienceTranslational ScienceClinical DevelopmentBusiness AspectsInvestor RelationsEmerging TechnologiesBiomarkers / DiagnosticsTrends in the Field Dr Axel Hoos, GSK and Dr James Gulley, NCI, together led the design of...

The Conference Forum is pleased to share a podcast featuring keynote speaker and world renowned customer service expert, Dr Chip Bell who spoke at the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on the topic of service in clinical trials. To truly service our patients, we need to understand service together with science. Can service be a disrupter in clinical research? In...

Originally recorded during the 4th annual Patients as Partners US event held in Philadelphia, March 2017, Bristol-Myers Squibb’s Mary Stober-Murray moderates this multi-stakeholder panel to discuss what patients truly want when it comes to clinical care and patient involvement. Patients John Creveling, a Parkinson’s Foundation Research Advocate, and Deb Maskens from the International Kidney Cancer...